The data indicates significant disparities in nervous system disease mortality rates among countries. Finland leads with the highest rate, while Peru records the lowest. Countries like the United States and Japan have shown notable increases in mortality, with the US experiencing a 6.01% year-on-year rise in 2023. Conversely, Spain and Luxembourg saw decreases. Colombia experienced the largest increase among the nations studied. The consistent upwards trends in countries like Croatia and Poland highlight areas for medical advancement and prevention strategies.
Future trends indicate a need to monitor increasing mortality rates in high-risk nations and evaluate factors contributing to lower rates in countries like Peru and Mexico. Emphasizing research and healthcare innovations will be crucial globally to manage and potentially reduce nervous system disease-related deaths.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Finland | 259.9 | 2023 | +2.89% | +2.73% | View data |
| 2 | 2 United States | 108.3 | 2023 | +4.54% | +6.01% | View data |
| 3 | 3 Iceland | 98.9 | 2023 | +2.28% | +0.081% | View data |
| 4 | 4 United Kingdom | 91.2 | 2023 | +5.19% | +5.55% | View data |
| 5 | 5 Sweden | 73.6 | 2023 | +2.51% | +2.8% | View data |
| 6 | 6 Spain | 62 | 2023 | -2.21% | -1.51% | View data |
| 7 | 7 Belgium | 59.2 | 2023 | +1.2% | +1.45% | View data |
| 8 | 8 Netherlands | 55.9 | 2023 | +2.01% | -0.56% | View data |
| 9 | 9 Denmark | 55.5 | 2023 | +2.78% | +3.03% | View data |
| 10 | 10 Japan | 49.5 | 2023 | +4.87% | +4.41% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...